ZACHARY JOHN CAPPELLO

Allopathic & Osteopathic Physicians|Otolaryngology CHARLOTTE, NC NPI 1295077014

General Payments — all program years on this page

$22,322.58

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $490.92 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $490.9219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $879.9910
2019 $523.027
2020 $75.844
2021 $5,057.8610
2022 $10,180.5631
2023 $5,114.3919
2024 $490.9219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077575276 Acclarent, Inc $31.82 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1098840644 Neurent Medical Limited $77.62 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110721976 Alcon Vision LLC $24.08 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018959 Regeneron Healthcare Solutions, Inc. $13.08 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018961 Regeneron Healthcare Solutions, Inc. $26.12 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018963 Regeneron Healthcare Solutions, Inc. $23.27 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018965 Regeneron Healthcare Solutions, Inc. $17.35 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114018967 Regeneron Healthcare Solutions, Inc. $37.49 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116524016 GlaxoSmithKline, LLC. $28.57 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903764 GENZYME CORPORATION $24.85 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903830 GENZYME CORPORATION $26.35 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903834 GENZYME CORPORATION $24.64 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903840 GENZYME CORPORATION $15.75 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903842 GENZYME CORPORATION $17.75 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903874 GENZYME CORPORATION $24.98 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139903890 GENZYME CORPORATION $21.74 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143873827 Checkpoint Surgical, Inc $17.42 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148783299 BIOTISSUE HOLDINGS INC. $19.02 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148787434 BIOTISSUE HOLDINGS INC. $19.02 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.